^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Validive (clonidine MBT)

    Associations

    News

    Trials
    Company:
    Monopar Therapeutics, Valerio Therap
    Drug class:
    α2 adrenergic receptor antagonist
    Related drugs:
    Associations

    News

    Trials
    over2years
    VOICE: Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer. (clinicaltrials.gov)
    P2b, N=190, Terminated, Monopar Therapeutics | N=330 --> 190 | Trial completion date: Dec 2025 --> May 2023 | Recruiting --> Terminated | Trial primary completion date: Feb 2024 --> May 2023; Interim Analysis did not meet the pre-defined threshold for efficacy of a 15% absolute difference in SOM prevention between Validive and placebo.
    Enrollment change • Trial completion date • Trial termination • Trial primary completion date
    |
    Validive (clonidine MBT)